These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6751622)

  • 1. [Effect of chronic insulin therapy on pancreatic A and B cell functions in type 2 diabetes].
    Tanaka A; Shima K
    Horumon To Rinsho; 1982 Jul; 30(7):693-8. PubMed ID: 6751622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes mellitus in patients with chronic alcoholic pancreatitis].
    Sadokov VM; Vinokurova LV
    Ter Arkh; 1993; 65(10):27-9. PubMed ID: 8296228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterogenous dysfunctions of pancreatic A and B cells in diabetes mellitus: a study by consecutive hyper-and hypoglycemic stimulation.
    Toyoshima H; Hanafusa T; Nonaka K; Tarui S
    Med J Osaka Univ; 1981 Mar; 31(3-4):93-100. PubMed ID: 7031453
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reversibility of pancreatic alpha- and beta-cell functions by exercise therapy in non-insulin dependent diabetes mellitus (NIDDM)].
    Nakamura K
    Horumon To Rinsho; 1982 Jul; 30(7):679-82. PubMed ID: 6751620
    [No Abstract]   [Full Text] [Related]  

  • 6. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 7. Parallel dysfunctions of pancreatic A, B and PP cells in insulin dependent diabetes.
    Nonaka K; Toyoshima H; Hanafusa T; Tarui S
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():127-33. PubMed ID: 7014203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
    Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB
    Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 11. [The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)].
    Schatz H; Pfeiffer EF
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):485-92. PubMed ID: 818514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 'artificial beta cell' for control of diabetes mellitus: effect on plasma glucagon levels.
    Horwitz DL; Gonen B; Jaspan JB; Langer BG; Rodman D; Zeidler A
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):639-44. PubMed ID: 394885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual pancreatic function in insulin dependent diabetics.
    Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA
    Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory B-cell activity in insulin dependent maturity-onset diabetic.
    Krause U; Faisst G; Cordes U; Beyer J
    Horm Metab Res; 1979 Apr; 11(4):261-5. PubMed ID: 378805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence of clinical remission and residual beta function during early stages of diabetes mellitus type I (author's transl)].
    Peig M; Reynals E; Gomis R; Millán M; Casamitjana R; Figuerola D
    Med Clin (Barc); 1982 Feb; 78(3):81-3. PubMed ID: 7043122
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucagon-stimulated plasma c-peptide in diabetics. Clinical parameters in the choice of therapy?].
    Urdahl P; Jørgensen HS
    Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1392-5. PubMed ID: 3529489
    [No Abstract]   [Full Text] [Related]  

  • 19. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.